MetaCap

Who Owns Satellos Bioscience Stock?

NASDAQ: MSLEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.49+0.145 (+1.97%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
49.70%
Institutional holders
30
  • Institutions 49.7%
  • Insiders 6.4%
  • Public and other 43.9%

Who owns Satellos Bioscience stock?

Institutional investors own about 49.7% of Satellos Bioscience's shares, spread across 30 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 6.37% of MSLE.

The largest institutional holders are Franklin Resources, Inc. (4.42%), Siren, L.L.C. (4.20%) and Vivo Capital, LLC (3.84%). Together, the top 10 institutions control 29.2% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their MSLE positions and 1 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of MSLE

Satellos Bioscience top institutional holders
InstitutionShares% HeldChange
Franklin Resources, Inc.938.67K4.42%0.0%
Siren, L.L.C.892.07K4.20%0.0%
Vivo Capital, LLC813.67K3.84%0.0%
Point72 Asset Management, L.P.682.70K3.22%-1.2%
Sphera Funds Management Ltd.652.59K3.08%+33.4%
Woodline Partners LP500.43K2.36%0.0%
Stonepine Capital Management, LLC491.62K2.32%+391.6%
Montanova Capital LLC475.00K2.24%0.0%
Avidity Partners Management, LP387.77K1.83%0.0%
Saturn V Capital Management LP350.00K1.65%0.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of MSLE

Satellos Bioscience top fund holders
FundShares% Held
Franklin Strategic Series-Franklin Biotechnology Discovery Fund343.24K1.62%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund13.02K0.06%

Frequently asked questions

Who is the largest shareholder of Satellos Bioscience?

Franklin Resources, Inc. is the largest institutional shareholder of MSLE, owning 4.42% of shares outstanding (938.67K shares) as of its latest 13F filing.

What percentage of Satellos Bioscience is owned by institutions?

Institutions own about 49.7% of MSLE shares and 53.1% of the public float.

How much of Satellos Bioscience do insiders own?

Insiders, such as officers and directors, own about 6.37% of MSLE shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related